These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 9224743)
21. Immunohistochemical analyses of CD44 variant isoforms in invasive micropapillary carcinoma of the breast: comparison with a concurrent conventional invasive carcinoma of no special type component. Umeda T; Ishida M; Murata S; Mori T; Kawai Y; Itoi N; Tomida K; Tanaka A; Sakai S; Kitamura M; Kubota Y; Kushima R; Tani M Breast Cancer; 2016 Nov; 23(6):869-875. PubMed ID: 26494575 [TBL] [Abstract][Full Text] [Related]
22. The new era in breast cancer. Invasion, size, and nodal involvement dramatically decreasing as a result of mammographic screening. Cady B; Stone MD; Schuler JG; Thakur R; Wanner MA; Lavin PT Arch Surg; 1996 Mar; 131(3):301-8. PubMed ID: 8611096 [TBL] [Abstract][Full Text] [Related]
23. HnRNPM and CD44s expression affects tumor aggressiveness and predicts poor prognosis in breast cancer with axillary lymph node metastases. Sun H; Liu T; Zhu D; Dong X; Liu F; Liang X; Chen C; Shao B; Wang M; Wang Y Genes Chromosomes Cancer; 2017 Aug; 56(8):598-607. PubMed ID: 28393427 [TBL] [Abstract][Full Text] [Related]
24. Inhibin/activin subunits (inhibin-alpha, -betaA and -betaB) are differentially expressed in human breast cancer and their metastasis. Mylonas I; Jeschke U; Shabani N; Kuhn C; Friese K; Gerber B Oncol Rep; 2005 Jan; 13(1):81-8. PubMed ID: 15583806 [TBL] [Abstract][Full Text] [Related]
25. Expression and significance of CD44s, CD44v6, and nm23 mRNA in human cancer. Liu YJ; Yan PS; Li J; Jia JF World J Gastroenterol; 2005 Nov; 11(42):6601-6. PubMed ID: 16425351 [TBL] [Abstract][Full Text] [Related]
26. The prognostic value of adhesion molecule CD44v6 in women with primary breast carcinoma: a clinicopathologic study. Ma W; Deng Y; Zhou L Clin Oncol (R Coll Radiol); 2005 Jun; 17(4):258-63. PubMed ID: 15997921 [TBL] [Abstract][Full Text] [Related]
27. Expression of CD44 standard form and variant isoforms in non-small cell lung carcinomas. Tran TA; Kallakury BV; Sheehan CE; Ross JS Hum Pathol; 1997 Jul; 28(7):809-14. PubMed ID: 9224749 [TBL] [Abstract][Full Text] [Related]
28. Comparison of Syndecan-1 Immunohistochemical Expression in Lobular and Ductal Breast Carcinoma with Nodal Metastases. Miše I; Vučić M Anal Cell Pathol (Amst); 2018; 2018():9432375. PubMed ID: 30151336 [TBL] [Abstract][Full Text] [Related]
29. The clinicopathological significance of CD44+/CD24-/low and CD24+ tumor cells in invasive micropapillary carcinoma of the breast. Li W; Liu F; Lei T; Xu X; Liu B; Cui L; Wei J; Guo X; Lang R; Fan Y; Gu F; Tang P; Zhang X; Fu L Pathol Res Pract; 2010 Dec; 206(12):828-34. PubMed ID: 20977976 [TBL] [Abstract][Full Text] [Related]
30. [Expression of the adhesion molecule CD44v6 in infiltrating ductal carcinomas of the breast is associated with hormone dependence. Our experience with 168 cases]. Ruibal A; Schneider J; del Río MC; Arias J; Núñez MI; Tejerina A Rev Esp Med Nucl; 2000 Sep; 19(5):350-5. PubMed ID: 11062111 [TBL] [Abstract][Full Text] [Related]
31. Expression of cell adhesion molecules, CD44s and E-cadherin, and microvessel density in invasive micropapillary carcinoma of the breast. Gong Y; Sun X; Huo L; Wiley EL; Rao MS Histopathology; 2005 Jan; 46(1):24-30. PubMed ID: 15656882 [TBL] [Abstract][Full Text] [Related]
32. Relation between Ki-67, ER, PR, Her2/neu, p21, EGFR, and TOP II-α expression in invasive ductal breast cancer patients and correlations with prognosis. Yan J; Liu XL; Han LZ; Xiao G; Li NL; Deng YN; Yin LC; Ling LJ; Yu XY; Tan CL; Huang XP; Liu LX Asian Pac J Cancer Prev; 2015; 16(2):823-9. PubMed ID: 25684532 [TBL] [Abstract][Full Text] [Related]
33. CD44 expression and axillary lymph node metastasis in infiltrating ductal carcinoma of the breast. Looi LM; Cheah PL; Zhao W; Ng MH; Yip CH Malays J Pathol; 2006 Dec; 28(2):83-6. PubMed ID: 18376796 [TBL] [Abstract][Full Text] [Related]
34. The prognostic significance of P-cadherin in infiltrating ductal breast carcinoma. Gamallo C; Moreno-Bueno G; Sarrió D; Calero F; Hardisson D; Palacios J Mod Pathol; 2001 Jul; 14(7):650-4. PubMed ID: 11454996 [TBL] [Abstract][Full Text] [Related]
35. [Expression of fatty acid synthase and its association with HER2 in invasive ductal carcinoma of breast]. Yang M; Xu SP; Ao QL Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):257-61. PubMed ID: 23928534 [TBL] [Abstract][Full Text] [Related]
36. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance. Nguyen VN; Mirejovský T; Melinová L; Mandys V Neoplasma; 2000; 47(6):400-8. PubMed ID: 11263866 [TBL] [Abstract][Full Text] [Related]
37. [Expression and clinical significance of adhesive molecule CD44v6 in breast invasive ductal carcinoma]. Lian ZQ; Yang MT; Hou JH; Luo RZ; Wang X; Tang J Ai Zheng; 2006 Oct; 25(10):1291-5. PubMed ID: 17059779 [TBL] [Abstract][Full Text] [Related]
38. CD44 expression is associated with increased survival in node-negative invasive breast carcinoma. Diaz LK; Zhou X; Wright ET; Cristofanilli M; Smith T; Yang Y; Sneige N; Sahin A; Gilcrease MZ Clin Cancer Res; 2005 May; 11(9):3309-14. PubMed ID: 15867228 [TBL] [Abstract][Full Text] [Related]
39. Rare breast cancer: 933 adenoid cystic carcinomas from the National Cancer Data Base. Kulkarni N; Pezzi CM; Greif JM; Suzanne Klimberg V; Bailey L; Korourian S; Zuraek M Ann Surg Oncol; 2013 Jul; 20(7):2236-41. PubMed ID: 23456318 [TBL] [Abstract][Full Text] [Related]
40. [Lymph node metastasis and prognostic analysis of 354 cases of T1 breast cancer]. Lyu Z; Wang J; Kang L; Hu C; He H; Guan M; Li J; Guan Y; Song Y Zhonghua Zhong Liu Za Zhi; 2014 May; 36(5):382-5. PubMed ID: 25030596 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]